# The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain

> **NCT01840345** · PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 11 (actual)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** N-acetyl-l-cysteine

## Key facts

- **NCT ID:** NCT01840345
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-04-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01840345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01840345, "The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01840345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*